skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Wiley Online Library Journals Frontfile Complete remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Multicenter randomized trial of arsenic trioxide and Realgar‐Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG‐APL clinical study
Multicenter randomized trial of arsenic trioxide and Realgar‐Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG‐APL clinical study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Multicenter randomized trial of arsenic trioxide and Realgar‐Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG‐APL clinical study

Yang, Ming‐Hua ; Wan, Wu‐Qing ; Luo, Jie‐Si ; Zheng, Min‐Cui ; Huang, Ke ; Yang, Li‐Hua ; Mai, Hui‐Rong ; Li, Jian ; Chen, Hui‐Qin ; Sun, Xiao‐Fei ; Liu, Ri‐Yang ; Chen, Guo‐Hua ; Feng, Xiaoqin ; Ke, Zhi‐Yong ; Li, Bin ; Tang, Yan‐Lai ; Huang, Li‐Bin ; Luo, Xue‐Qun

American journal of hematology, 2018-12, Vol.93 (12), p.1467-1473 [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
2
Long‐term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide‐based reinduction and maintenance regimens: A 15‐year prospective study
Long‐term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide‐based reinduction and maintenance regimens: A 15‐year prospective study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long‐term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide‐based reinduction and maintenance regimens: A 15‐year prospective study

Gill, Harinder ; Yim, Rita ; Lee, Harold K. K. ; Mak, Vivien ; Lin, Shek‐Ying ; Kho, Bonnie ; Yip, Sze‐Fai ; Lau, June S. M. ; Li, Wah ; Ip, Ho‐Wan ; Hwang, Yu‐Yan ; Chan, Thomas S. Y. ; Tse, Eric ; Au, Wing‐Yan ; Kumana, Cyrus R. ; Kwong, Yok‐Lam

Cancer, 2018-06, Vol.124 (11), p.2316-2326 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
3
Resource utilization and cost effectiveness of treating acute promyelocytic leukaemia using generic arsenic trioxide
Resource utilization and cost effectiveness of treating acute promyelocytic leukaemia using generic arsenic trioxide
Material Type:
Artigo 		Adicionar ao Meu Espaço

Resource utilization and cost effectiveness of treating acute promyelocytic leukaemia using generic arsenic trioxide

Bankar, Aniket ; Korula, Anu ; Kulkarni, Uday P. ; Devasia, Anup J. ; NA, Fouzia ; Lionel, Sharon ; Abraham, Aby ; Balasubramanian, Poonkuzhali ; Janet, Nancy Beryl ; Nair, Sukesh C. ; S, Sezlian ; Jeyaseelan, Visali ; N, Jeyaseelan ; Prasad, Jasmine ; George, Biju ; Mathews, Vikram

British journal of haematology, 2020-04, Vol.189 (2), p.269-278 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
4
Management of relapse in acute promyelocytic leukaemia treated with up‐front arsenic trioxide‐based regimens
Management of relapse in acute promyelocytic leukaemia treated with up‐front arsenic trioxide‐based regimens
Material Type:
Artigo 		Adicionar ao Meu Espaço

Management of relapse in acute promyelocytic leukaemia treated with up‐front arsenic trioxide‐based regimens

Fouzia, N. A. ; Sharma, Vibhor ; Ganesan, Saravanan ; Palani, Hamenth K. ; Balasundaram, Nithya ; David, Sachin ; Kulkarni, Uday P. ; Korula, Anu ; Devasia, Anup J. ; Nair, Sukesh C. ; Janet, Nancy Beryl ; Abraham, Aby ; Mani, Thenmozhi ; Lakshmanan, Jeyaseelan ; Balasubramanian, Poonkuzhali ; George, Biju ; Mathews, Vikram

British journal of haematology, 2021-01, Vol.192 (2), p.292-299 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
5
Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study
Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study

Gill, Harinder ; Kumana, Cyrus R. ; Yim, Rita ; Hwang, Yu‐Yan ; Chan, Thomas S. Y. ; Yip, Sze‐Fai ; Lee, Harold K. K. ; Mak, Vivien ; Lau, June S. M. ; Chan, Chi‐Chung ; Kho, Bonnie ; Wong, Raymond S. M. ; Li, Wa ; Lin, Shek‐Yin ; Lau, Chi‐Kuen ; Ip, Ho‐Wan ; Leung, Rock Y. Y. ; Lam, Clarence C. K. ; Kwong, Yok‐Lam

Cancer, 2019-09, Vol.125 (17), p.3001-3012 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
6
Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells
Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells

Zhang, Bing-Bing ; Chen, Xiao-Jie ; Fan, Xu-Dong ; Zhu, Jing-Jing ; Wei, Ying-Hui ; Zheng, Hang-Sheng ; Zheng, Hong-Yue ; Wang, Bin-Hui ; Piao, Ji-Gang ; Li, Fan-Zhu

Acta pharmacologica Sinica, 2021-05, Vol.42 (5), p.832-842 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Arsenic trioxide and all‐trans retinoic acid treatment for childhood acute promyelocytic leukaemia
Arsenic trioxide and all‐trans retinoic acid treatment for childhood acute promyelocytic leukaemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Arsenic trioxide and all‐trans retinoic acid treatment for childhood acute promyelocytic leukaemia

Strocchio, Luisa ; Gurnari, Carmelo ; Santoro, Nicola ; Putti, Maria C. ; Micalizzi, Concetta ; Zecca, Marco ; Cuccurullo, Rosanna ; Girardi, Katia ; Diverio, Daniela ; Testi, Anna M. ; Lo‐Coco, Francesco ; Locatelli, Franco

British journal of haematology, 2019-04, Vol.185 (2), p.360-363 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
8
Bcl‐2 hijacks the arsenic trioxide resistance in SH‐SY5Y cells
Bcl‐2 hijacks the arsenic trioxide resistance in SH‐SY5Y cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bcl‐2 hijacks the arsenic trioxide resistance in SH‐SY5Y cells

Wang, Jinling ; Peng, Xiaohui ; Yang, Daowei ; Guo, Mengyu ; Xu, Xiao ; Yin, Fengyue ; Wang, Yu ; Huang, Jiaqing ; Zhan, Linghui ; Qi, Zhongquan

Journal of cellular and molecular medicine, 2022-01, Vol.26 (2), p.563-569 [Periódico revisado por pares]

England: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
9
Antitumor efficacy of arsenic/interferon in preclinical models of chronic myeloid leukemia resistant to tyrosine kinase inhibitors
Antitumor efficacy of arsenic/interferon in preclinical models of chronic myeloid leukemia resistant to tyrosine kinase inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antitumor efficacy of arsenic/interferon in preclinical models of chronic myeloid leukemia resistant to tyrosine kinase inhibitors

El Eit, Rabab ; Itani, Abdul Rahman ; Nassar, Farah ; Rasbieh, Nagham ; Jabbour, Mark ; Santina, Ahmad ; Zaatari, Ghazi ; Mahon, François‐Xavier ; Bazarbachi, Ali ; Nasr, Rihab

Cancer, 2019-08, Vol.125 (16), p.2818-2828 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
10
Arsenic trioxide inhibits the differentiation of fibroblasts to myofibroblasts through nuclear factor erythroid 2‐like 2 (NFE2L2) protein and the Smad2/3 pathway
Arsenic trioxide inhibits the differentiation of fibroblasts to myofibroblasts through nuclear factor erythroid 2‐like 2 (NFE2L2) protein and the Smad2/3 pathway
Material Type:
Artigo 		Adicionar ao Meu Espaço

Arsenic trioxide inhibits the differentiation of fibroblasts to myofibroblasts through nuclear factor erythroid 2‐like 2 (NFE2L2) protein and the Smad2/3 pathway

Zhong, Lingzhi ; Hao, Haojie ; Chen, Deyun ; Hou, Qian ; Zhu, Ziying ; He, Wenjun ; Sun, Sujing ; Sun, Mengli ; Li, Meirong ; Fu, Xiaobing

Journal of cellular physiology, 2019-03, Vol.234 (3), p.2606-2617 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (311)
  2. Revistas revisadas por pares (312)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (316)
  2. Reports  (3)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1995  (10)
  2. 1995Até2003  (56)
  3. 2004Até2010  (71)
  4. 2011Até2018  (85)
  5. Após 2018  (98)
  6. Mais opções open sub menu

Idioma 

  1. Japonês  (62)
  2. Alemão  (1)
  3. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.